View in EDS HTML Full Text PDF Full Text

Acalabrutinib in High-Risk Chronic Lymphocytic Leukaemia Naïve Patients: An Italian Multicenter Retrospective Observational Real-Life Experience.

Saved in:
Bibliographic Details
Title: Acalabrutinib in High-Risk Chronic Lymphocytic Leukaemia Naïve Patients: An Italian Multicenter Retrospective Observational Real-Life Experience.
Authors: Innocenti I; Department of Laboratory and Haematological Sciences, Haematology Area, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma, Italy., Tomasso A; Hematology Section, Department of Radiological and Hematological Sciences, Università Cattolica del Sacro Cuore, Roma, Italy., Giannarelli D; Facility of Epidemiology and Biostatistics, GSTeP, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy., Scarfò L; Strategic Research Program on CLL, IRCSS San Raffaele, Milano, Italy.; Medical School, Università Vita Salute San Raffaele, Milano, Italy., Murru R; Hematology and Stem Cell Transplantation Unit, Ospedale Oncologico A. Businco, ARNAS G. Brotzu, Cagliari, Italy., Visentin A; Hematology Unit, Department of Medicine-DIMED, University of Padua, Padova, Italy., Frustaci AM; Department of Hematology, Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy., Morelli F; Department of Experimental and Clinical Medicine, University of Florence, Firenze, Italy., Vitale C; Department of Molecular Biotechnology and Health Sciences, University of Torino and Division of Hematology, University Hospital (A.O.U.) Città della Salute e della Scienza di Torino, Torino, Italy., Mosca A; Hematology Section, Department of Radiological and Hematological Sciences, Università Cattolica del Sacro Cuore, Roma, Italy., Sanna A; Hematology, Department of Oncology, AOU Careggi, Firenze, Italy., Farina G; Hematology and Medical Oncology, AORN Sant'Anna e San Sebastiano, Caserta, Italy., Laureana R; Hematology, Department of Biomedicine and Prevention Tor Vergata, University of Rome, Roma, Italy., Gentile M; Hematology Unit AO of Cosenza, Cosenza, Italy.; Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Rende, Italy., Galitzia A; Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy., Pasquale R; SOC Clinica Ematologia, Azienda Sanitaria Universitaria Friuli Centrale (ASU FC), Udine, Italy., Autore F; Department of Laboratory and Haematological Sciences, Haematology Area, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma, Italy., Olivieri J; SOC Clinica Ematologia, Azienda Sanitaria Universitaria Friuli Centrale (ASU FC), Udine, Italy., Romeo A; Hematology and Stem Cell Transplantation Unit, S.M. Goretti Hospital, Polo Universitario Pontino, Latina, Italy., Deodato M; Department of Hematology, Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy., Stirparo L; Hematology Section, Department of Radiological and Hematological Sciences, Università Cattolica del Sacro Cuore, Roma, Italy., Corbingi A; Hematology and Stem Cell Transplantation Unit, S.M. Goretti Hospital, Polo Universitario Pontino, Latina, Italy., Innao V; UOC di Ematologia, Azienda Ospedaliera di rilievo nazionale di alta specializzazione, ARNAS-Garibaldi di Catania, Catania, Italy., Perutelli F; Department of Molecular Biotechnology and Health Sciences, University of Torino and Division of Hematology, University Hospital (A.O.U.) Città della Salute e della Scienza di Torino, Torino, Italy., Martini F; Strategic Research Program on CLL, IRCSS San Raffaele, Milano, Italy., Sportoletti P; Department of Medicine and Surgery, Institute of Hematology, Centro di Ricerca Emato Oncologica (CREO), University of Perugia, Perugia, Italy., Fresa A; Hematology Section, Department of Radiological and Hematological Sciences, Università Cattolica del Sacro Cuore, Roma, Italy.; Hematology-Oncology and Stem-Cell Transplantation Unit, Department of Onco-Hematology and Innovative Diagnostics, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Napoli, Italy., Del Principe MI; Hematology, Department of Biomedicine and Prevention Tor Vergata, University of Rome, Roma, Italy., Tedeschi A; Department of Hematology, Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy., Coscia M; Department of Medicine and Surgery, University of Insubria, and Hematology Division, ASST Sette Laghi, Ospedale di Circolo, Varese, Italy., Ghia P; Strategic Research Program on CLL, IRCSS San Raffaele, Milano, Italy.; Medical School, Università Vita Salute San Raffaele, Milano, Italy., Laurenti L; Department of Laboratory and Haematological Sciences, Haematology Area, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma, Italy.; Hematology Section, Department of Radiological and Hematological Sciences, Università Cattolica del Sacro Cuore, Roma, Italy.
Source: Hematological oncology [Hematol Oncol] 2025 Jan; Vol. 43 (1), pp. e70033.
Publication Type: Letter
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8307268 Publication Model: Print Cited Medium: Internet ISSN: 1099-1069 (Electronic) Linking ISSN: 02780232 NLM ISO Abbreviation: Hematol Oncol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1099-1069
DOI:10.1002/hon.70033